GlassScriptPhysician profile
Rodney T Mccalla
NPI 1477545671
$3,603.74
in general payments reported to CMS, 2019-2025
21 companies · $346 in 2025
The $346 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $213 · 2020: $28.63 · 2021: $11.66 · 2022: $2,077 · 2023: $594 · 2024: $333 · 2025: $346.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,273.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,273.36 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,445.91 | 2019-2022 | |
| Medtronic, INC. | $1,339.44 | 2021-2025 | Endoflip, Bravo, Gi Genius |
| Lucid Diagnostics INC. | $164.56 | 2023-2024 | |
| Jazz Pharmaceuticals INC. | $89.53 | 2025 | |
| Genzyme Corporation | $64.52 | 2024-2025 | |
| Merck Sharp & Dohme LLC | $58.28 | 2019-2023 | |
| Abbvie INC. | $54.69 | 2020-2025 | |
| Karl Storz Endoscopy-America | $51.42 | 2023 | Tele Pack |
| Stryker Corporation | $50.59 | 2024 | Scopis Ent |
| Melinta Therapeutics, LLC | $47.72 | 2024-2025 | Kimyrsa, Rezzayo, Orbactiv |
| Acclarent, INC | $35.38 | 2022 | |
| Endogastric Solutions, INC | $32.96 | 2022-2024 | Esophyx |
| Ambu INC. | $32.64 | 2023 | |
| Paratek Pharmaceuticals, INC. | $28.01 | 2025 | Nuzyra |
| Glaxosmithkline, LLC. | $20.22 | 2022 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $17.13 | 2025 | |
| Phathom Pharmaceuticals, INC. | $16.66 | 2025 | Voquezna |
| Biocomposites INC | $15.73 | 2023 | Stimulan |
| Innocoll Pharmaceuticals Limited | $15.24 | 2022 | |
| Merit Medical Systems INC | $11.94 | 2024 | Esophyx |
| Osiris Therapeutics INC. | $11.17 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rodney Mccalla listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.